EXAS Projected Dividend Yield
EXACT Sciences Corp. ( NASDAQ : EXAS )Exact Sciences Corporation is a global advanced cancer diagnostics company. Co. provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. Co. is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. Co.'s products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, and OncoExTra Test. 21 YEAR PERFORMANCE RESULTS |
EXAS Dividend History Detail EXAS Dividend News EXAS Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |